HSP90AA1 and neoplasm: Our results confirmed that PEPE2 treatment increased the Thr845 phosphorylation of ASK-1 and downregulated the ser83 phosphorylation in UBUC cells, suggesting that the PEPE2 cure likely intervented the HSP90/Akt-1/Ask-1 pathway to induce tumor cell apoptosis.